Valcyte Articles
New Zealand's PHARMAC decisions on Roche products
11 October 2012
Roche's Valcyte works up to 200 days; trial
23 February 2009
Valcyte as effective as ganciclovir in CMV
14 May 2007
Positive new data for Roche's ganciclovir
31 May 2004
Roche's Valcyte comparable to Cytovene
9 June 2003
Roche's Fuzeon cleared in Switzerland
2 June 2003
Roche's Valcyte approved for CMV in Europe
18 March 2002
Update: Roche's Valcyte gets 1st EU approval in Holland
2 October 2001
Roche's Valcyte approved in Holland
27 September 2001
Roche's oral anti-CMV prodrug approved
5 April 2001
Showing 1-16 of 16 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
